Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qol Holdings CoTSE:3034 -0.43%88 PB Ratio is 1.37 as of Jul. 23, 2026, which is 2% above its 10-year median of 1.34. GuruFocus rates TSE:3034 with a GF Score™ of 88/100 and a GF Value™ of 円2,286.16 (Fairly Valued). The stock has 1 warning sign investors should review. Among 607 Healthcare Providers & Services companies, Qol Holdings Co ranks better than 65.4% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-23), Qol Holdings Co's share price is 円2090.00. Qol Holdings Co's Book Value per Share for the quarter that ended in Mar. 2026 was 円1,528.85. Hence, Qol Holdings Co's PB Ratio of today is 1.37.
The historical rank and industry rank for Qol Holdings Co's PB Ratio or its related term are showing as below:
TSE:3034'
s PB Ratio Range Over the Past 10 Years
Min: 0.88 Med: 1.34 Max: 3.01
Current: 1.36
During the past 13 years, Qol Holdings Co's highest PB Ratio was 3.01. The lowest was 0.88. And the median was 1.34.
TSE:3034's PB Ratio is ranked better than 65.4% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 1.99
vs TSE:3034: 1.36
During the past 12 months, Qol Holdings Co's average Book Value Per Share Growth Rate was 0.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Qol Holdings Co was 136.00% per year. The lowest was 4.50% per year. And the median was 8.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Qol Holdings Co PB Ratio Related Terms
Qol Holdings Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Qol Holdings Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Qol Holdings Co (TSE:3034) has a PB Ratio of 1.37 as of Jul. 23, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Qol Holdings Co and its competitors. This is near median its historical median of 1.34. Over the past decade, Qol Holdings Co's PB Ratio has ranged from 0.88 to 3.01. According to the industry distribution chart, Qol Holdings Co ranks #210 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 34.6%.
Is Qol Holdings Co's PB Ratio too high?
Qol Holdings Co's current PB Ratio of 1.37 is near median its 10-year median of 1.34. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 3.01. The Healthcare Providers & Services industry median PB Ratio is 1.99. Qol Holdings Co's value of 1.37 is 31.2% below this industry median. Based on the distribution chart, Qol Holdings Co ranks #210 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Qol Holdings Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qol Holdings Co ranks #210 out of 607 companies for PB Ratio. This puts Qol Holdings Co in the upper half of its industry. The industry median PB Ratio is 1.99. Qol Holdings Co's value of 1.37 is 31.2% below this benchmark. Historically, Qol Holdings Co's own PB Ratio has ranged from 0.88 to 3.01 over the past decade. While the company's 10-year median is 1.34 vs. the industry median of 1.99, Qol Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qol Holdings Co's current PB Ratio of 1.37 is 31.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Qol Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qol Holdings Co's current PB Ratio is 1.37, which is near median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Fairly Valued. The stock's GF Value™ is 円2,286.16, compared to a current price of 円2,090.00 — trading 8.6% below its estimated fair value. The current PB Ratio is 1.37, which is near median its 10-year median of 1.34 and 31.2% below the Healthcare Providers & Services industry median of 1.99. Qol Holdings Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current PB Ratio is 1.37 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be undervalued.
The current stock price of 円2,090.00 is trading 8.6% below its estimated GF Value™ of 円2,286.16.
GuruFocus considers Qol Holdings Co to be Fairly Valued.
Key valuation signals for TSE:3034:
PB Ratio: 1.37 (near median its 10-year median of 1.34)
GF Value™: 円2,286.16 vs. price of 円2,090.00 (8.6% below fair value)
Industry Position: 31.2% below the Healthcare Providers & Services median (#210 of 607)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
88GF Score
Get the complete analysis for TSE:3034
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
